Adaptin Bio, Inc.
APTN
$6.27
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 20.75% | -90.03% | -59.66% | -51.28% | -85.77% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -100.00% | -100.00% |
| Total Other Non-Cash Items | 77.52% | 207.94% | -12.91% | 5,062.90% | 10,316.67% |
| Change in Net Operating Assets | 25.47% | 114.49% | -25.80% | 5.83% | -57.93% |
| Cash from Operations | 55.98% | 73.85% | -723.69% | -64.90% | -401.82% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 66.40% | -- | -- | -- |
| Issuance of Common Stock | -- | -89.42% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 90.43% | -115.06% | 100.00% | -- |
| Cash from Financing | -- | -90.51% | 400.67% | -100.00% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 136.10% | -106.75% | -47.66% | -944.15% | -5,568.98% |